相关实验视频

Updated: Jun 15, 2025

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.7K

使用下一代测序进行P53免疫组织化学和TP53突变分析的现实世界比较

Hyunwoo Lee1, Yoon Ah Cho1, Deok Geun Kim2,3

  • 1Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Anticancer research
|August 28, 2024
PubMed
概括

乳腺癌 (BC) 的TP53突变与糟糕的结果有关. P53免疫组织化学 (IHC) 是TP53突变的可靠替代标记物,而异常的p53积累预测化学抵抗.

关键词:
乳腺癌 乳腺癌 乳腺癌这种突变是TP53突变.这是下一代测序.p53 免疫组织化学预后 预后 预后

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.8K

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.5K